Treatment with Statins Does Not Revert Trained Immunity in Patients with Familial Hypercholesterolemia
- PMID: 31204280
- DOI: 10.1016/j.cmet.2019.05.014
Treatment with Statins Does Not Revert Trained Immunity in Patients with Familial Hypercholesterolemia
Abstract
Individuals with elevated LDL-cholesterol levels have an increased risk for cardiovascular disease. Despite lipid lowering strategies, however, a significant cardiovascular risk remains. Bekkering et al. show that monocytes from patients with familial hypercholesterolemia have a trained immunity phenotype and that lipid lowering with statins does not revert this pro-inflammatory phenotype.
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
-
Reducing cardiovascular risk in patients with familial hypercholesterolemia: Risk prediction and lipid management.Prog Cardiovasc Dis. 2019 Sep-Oct;62(5):414-422. doi: 10.1016/j.pcad.2019.10.003. Epub 2019 Oct 25. Prog Cardiovasc Dis. 2019. PMID: 31669498 Review.
-
Long-Term Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia Relatives Identified by Cascade Screening.J Am Heart Assoc. 2017 Jun 26;6(6):e005435. doi: 10.1161/JAHA.116.005435. J Am Heart Assoc. 2017. PMID: 28652386 Free PMC article.
-
Statins for children with familial hypercholesterolemia.Cochrane Database Syst Rev. 2014 Jul 23;(7):CD006401. doi: 10.1002/14651858.CD006401.pub3. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2017 Jul 07;7:CD006401. doi: 10.1002/14651858.CD006401.pub4 PMID: 25054950 Updated. Review.
-
Real-life LDL-C treatment goals achievement in patients with heterozygous familial hypercholesterolemia in the Czech Republic and Slovakia: Results of the PLANET registry.Atherosclerosis. 2018 Oct;277:355-361. doi: 10.1016/j.atherosclerosis.2018.08.008. Atherosclerosis. 2018. PMID: 30270071
-
LDL-cholesterol target achievement in patients with heterozygous familial hypercholesterolemia at Groote Schuur Hospital: Minority at target despite large reductions in LDL-C.Atherosclerosis. 2018 Oct;277:327-333. doi: 10.1016/j.atherosclerosis.2018.06.820. Atherosclerosis. 2018. PMID: 30270067
Cited by
-
Intermediate Monocytes and Circulating Endothelial Cells: Interplay with Severity of Atherosclerosis in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus.Biomedicines. 2023 Oct 27;11(11):2911. doi: 10.3390/biomedicines11112911. Biomedicines. 2023. PMID: 38001912 Free PMC article.
-
Bone marrow inflammatory memory in cardiometabolic disease and inflammatory comorbidities.Cardiovasc Res. 2024 Feb 17;119(18):2801-2812. doi: 10.1093/cvr/cvad003. Cardiovasc Res. 2024. PMID: 36655373 Free PMC article. Review.
-
oxLDL-Induced Trained Immunity Is Dependent on Mitochondrial Metabolic Reprogramming.Immunometabolism. 2021 Jun 30;3(3):e210025. doi: 10.20900/immunometab20210025. eCollection 2021. Immunometabolism. 2021. PMID: 34267957 Free PMC article.
-
Increased innate immune responses in adolescents with obesity and its relation to subclinical cardiovascular measures: An exploratory study.iScience. 2024 Apr 23;27(5):109762. doi: 10.1016/j.isci.2024.109762. eCollection 2024 May 17. iScience. 2024. PMID: 38741712 Free PMC article.
-
Multifaceted roles of trained immunity in diverse pathological contexts.BMB Rep. 2024 Oct;57(10):431-440. doi: 10.5483/BMBRep.2024-0045. BMB Rep. 2024. PMID: 38835118 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
